Page 1 Page 2 Page 3 Page 4 Page 5 Page 6 Page 7 Page 8 Page 9 Page 10 Page 11 Page 12 Page 13 Page 14 Page 15 Page 16 Page 17 Page 18 Page 19 Page 20 Page 21 Page 22 Page 23 Page 24 Page 25 Page 26 Page 27 Page 28 Page 29 Page 30 Page 31 Page 32 Page 33 Page 34 Page 35 Page 36 Page 37 Page 38 Page 39 Page 40 Page 41 Page 42 Page 43 Page 44Program at a Glance 5 Workshops & Symposia at the 2017 ACCP Annual Meeting are identified as being part of either the “Discovery Track” (DT) or the “Application Track” (AT) to make it easier for attendees to determine which courses they prefer to attend. ng Trends Data Analysis Data Analysis Biosimilars ernative Medicine Individualized Care MONDAY, SEPTEMBER 18, 2017 Symposium 6 l 8:00 – 9:30 am Therapeutic Options for Obesity Treatment in Children, Adolescents & Young Adults (AT) This Symposium is supported in part by the British Journal of Clinical Pharmacology. CO-CHAIRS: Catherine MT Sherwin, PhD, MS, Chief, Div of Clinical Pharmacology, Univ of Utah and Janelle D. Vaughns, MD, Assistant Professor of Anesthesiology & Pediatrics, Children’s National Health System Symposium 7 l 8:00 am – 12:00 pm Modeling of Adherence: Applications in Drug Development & Clinical Practice (DT) CO-CHAIRS: Ayyappa Chaturvedula, PhD, Associate Professor, Univ of North Texas System Coll of Pharmacy and Mark Sale, MD, Senior Vice President, Nuventra Pharma Sciences Symposium 8 l 10:00 am – 12:00 pm Kinase Inhibitors in Pediatric Patients: Experiences, Pharmacology & Future Applications (DT) CO-CHAIRS: Jonathan Constance, PhD, Assistant Professor, Univ of Utah and G. W. ‘t Jong, MD, PhD, Academic Pediatrician & Clinical Pharmacologist, Assistant Professor of Pediatrics, Internal Medicine & Pharmacology, Univ of Manitoba Symposium 9 l 1:30 – 3:30 pm What to Do After a Pivotal Trial Has Failed Primary Endpoint Assessment: Totality of Evidence-based Drug Development Challenges & Opportunities (AT) CHAIR: Yan Xu, PhD, Associate Scientific Director, Global Clinical Pharmacology, Janssen: Pharmaceutical Co of Johnson & Johnson Symposium 10 l 1:30 – 5:30 pm Challenges & Opportunities in the Development of Inhaled Medicines (DT) CO-CHAIRS: Clive Page, BSc, PhD, Professor of Pharmacology, Sackler Inst of Pulmonary Pharmacology, King’s Coll and Anne Lexmond, PharmD, PhD, Dept of Pharmaceutical Technology & Biopharmacy, Univ of Groningen Symposium 11 l 4:00 – 5:30 pm Pioneering NAFLD/NASH Early-phase Clinical Pharmacology Study Designs (DT) CO-CHAIRS: Lorraine Rusch, PhD, President, High Point Clinical Trials Ctr and Sabina Paglialunga, PhD, Metabolic & Pharmacodynamic Specialist, Celerion TUESDAY, SEPTEMBER 19, 2017 Symposium 12 l 8:00 – 9:30 am Assessment of Drug Effect on Pediatric Bone Health (DT) CHAIR: Gilbert J. Burckart, PharmD, Associate Director of Pediatrics, Office of Clinical Pharmacology, Ctr for Drug Evaluation & Research, US Food & Drug Administration Symposium 13 l 8:00 am – 12:00 pm 21st Century HIV/AIDS: An Evolving Drug Development & Technology Paradigm (DT) CO-CHAIRS: Jomy George, PharmD, Pharmacokineticist, National Inst of Health and Parag Kumar, PharmD, Director, Clinical Pharmacokinetics Research Unit, National Inst of Health Symposium 14 l 10:00 am – 12:00 pm Full Extrapolation of Efficacy from Adults to Children of Antiepileptic Drugs Indicated for the Treatment of Partial Onset Seizures (AT) CHAIR: Angela Men, PhD, MD, Pharmacology Lead, US Food & Drug Administration Symposium 15 l 1:30 – 5:30 pm Biosimilars: An Evolving Science (DT) CO-CHAIRS: Darrell R. Abernethy, MD, PhD, Associate Director for Drug Safety, Office of Clinical Pharmacology, US Food & Drug Administration and Bernd Meibohm, PhD, Professor & Associate Dean, Univ of Tennessee Health Science Ctr, Coll of Pharmacy Symposium 16 l 1:30 – 5:30 pm Opioid Abuse & Misuse: A Rising Epidemic in America (AT) CO-CHAIRS: Sam Harirforoosh, PharmD, PhD, Associate Professor, Gatton Coll of Pharmacy and Arsham Alamian, PhD, MSc, MACE, Assistant Professor, Coll of Public Health, East Tennessee State Univ TUESDAY, SEPTEMBER 19, 2017 MONDAY, SEPTEMBER 18, 2017